Yvonne Liss

Summary

Affiliation: University Hospital
Country: Germany

Publications

  1. doi request reprint A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis
    Ella Neumann
    Department of Dermatology, University Medical Center, Freiburg, Germany
    J Dtsch Dermatol Ges 6:548-53. 2008
  2. doi request reprint Epidemiology of cutaneous adverse drug reactions
    Maja Mockenhaupt
    Dokumentationszentrum schwerer Hautreaktionen, Department of Dermatology, University Freiburg Medical Center, Freiburg, Germany
    Chem Immunol Allergy 97:1-17. 2012
  3. pmc Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
    Emmanuelle Genin
    INSERM U, Paris, France
    Orphanet J Rare Dis 6:52. 2011
  4. doi request reprint Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy
    Maja Mockenhaupt
    Center for Documentation of Severe Skin Reactions, Department of Dermatology, University Medical Center Freiburg, Hauptstrasse 7, Freiburg
    J Dtsch Dermatol Ges 7:142-60; quiz 161-2. 2009
  5. doi request reprint The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Maja Mockenhaupt
    The German Registry on Severe Skin Reactions, Department of Dermatology, University of Freiburg, Freiburg, Germany
    Expert Rev Clin Immunol 7:803-13; quiz 814-5. 2011
  6. ncbi request reprint Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
    Maja Mockenhaupt
    Dokumentationszentrum schwerer Hautreaktionen, Department of Dermatology, University Medical Center, Freiburg, Germany
    J Invest Dermatol 128:35-44. 2008
  7. doi request reprint Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
    Peggy Sekula
    Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Freiburg, Germany
    J Invest Dermatol 133:1197-204. 2013
  8. ncbi request reprint Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis
    Mirjana Ziemer
    Department of Dermatology, University of Jena, Erfurter Strasse 35, D 07743 Jena, Germany
    Arch Dermatol 143:711-6. 2007
  9. ncbi request reprint Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study
    Jürgen Schneck
    Dokumentationszentrum schwerer Hautreaktionen, University Medical Center Freiburg, Freiburg, Germany
    J Am Acad Dermatol 58:33-40. 2008
  10. ncbi request reprint Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics
    Maja Mockenhaupt
    University of Freiburg, Freiburg, Germany
    Neurology 64:1134-8. 2005

Collaborators

Detail Information

Publications13

  1. doi request reprint A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis
    Ella Neumann
    Department of Dermatology, University Medical Center, Freiburg, Germany
    J Dtsch Dermatol Ges 6:548-53. 2008
    ..This long-term study compares the efficacy of tacrolimus 0.1% ointment with topical corticosteroids as standard therapy in patients with moderate atopic dermatitis...
  2. doi request reprint Epidemiology of cutaneous adverse drug reactions
    Maja Mockenhaupt
    Dokumentationszentrum schwerer Hautreaktionen, Department of Dermatology, University Freiburg Medical Center, Freiburg, Germany
    Chem Immunol Allergy 97:1-17. 2012
    ..Drug reaction with eosinophilia and systemic symptoms can be induced by a number of drugs known to cause SJS/TEN, such as certain antiepileptics and allopurinol, but also other medications (e.g. minocyclin)...
  3. pmc Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
    Emmanuelle Genin
    INSERM U, Paris, France
    Orphanet J Rare Dis 6:52. 2011
    ..Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare but extremely severe cutaneous adverse drug reactions in which drug-specific associations with HLA-B alleles were described...
  4. doi request reprint Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy
    Maja Mockenhaupt
    Center for Documentation of Severe Skin Reactions, Department of Dermatology, University Medical Center Freiburg, Hauptstrasse 7, Freiburg
    J Dtsch Dermatol Ges 7:142-60; quiz 161-2. 2009
    ..The prognosis of GBFDE is better but recurrent events may lead to more severe involvement. In HSS/DRESS sequelae have been also described as well as long lasting and recurrent courses, whereas AGEP usually heals without problems...
  5. doi request reprint The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Maja Mockenhaupt
    The German Registry on Severe Skin Reactions, Department of Dermatology, University of Freiburg, Freiburg, Germany
    Expert Rev Clin Immunol 7:803-13; quiz 814-5. 2011
    ..Survivors may suffer from long-term sequelae such as strictures of mucous membranes including severe eye problems...
  6. ncbi request reprint Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
    Maja Mockenhaupt
    Dokumentationszentrum schwerer Hautreaktionen, Department of Dermatology, University Medical Center, Freiburg, Germany
    J Invest Dermatol 128:35-44. 2008
    ..The use of such drugs as first-line therapies should be considered carefully, especially when safer alternative treatments exist. A number of widely used drugs did not show any risk for SJS and TEN...
  7. doi request reprint Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
    Peggy Sekula
    Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Freiburg, Germany
    J Invest Dermatol 133:1197-204. 2013
    ....
  8. ncbi request reprint Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis
    Mirjana Ziemer
    Department of Dermatology, University of Jena, Erfurter Strasse 35, D 07743 Jena, Germany
    Arch Dermatol 143:711-6. 2007
    ..To assess the type of severe skin reactions caused by valdecoxib treatment...
  9. ncbi request reprint Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study
    Jürgen Schneck
    Dokumentationszentrum schwerer Hautreaktionen, University Medical Center Freiburg, Freiburg, Germany
    J Am Acad Dermatol 58:33-40. 2008
    ..No treatment modality has been established as standard for patients with Stevens-Johnson syndrome and toxic epidermal necrolysis...
  10. ncbi request reprint Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics
    Maja Mockenhaupt
    University of Freiburg, Freiburg, Germany
    Neurology 64:1134-8. 2005
    ..Because the risk of SJS is highest in new users of drugs, the use of denominators reflective of all users can lead to low estimates of risk associated with drugs. In this study, risk in new users is assessed...
  11. doi request reprint Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study
    Peggy Sekula
    Department of Medical Biometry and Statistics, Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Germany
    J Burn Care Res 32:237-45. 2011
    ..Although improvement might be possible, SCORTEN remains the tool of choice, whereas AS might be an alternative in retrospective settings with missing laboratory data...
  12. ncbi request reprint The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective
    Maja Mockenhaupt
    Dokumentationszentrum schwerer Hautreaktionen, Freiburg, Germany
    J Rheumatol 30:2234-40. 2003
    ..To quantify the risk of the severe cutaneous adverse reactions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) associated with use of nonsteroidal antiinflammatory drugs (NSAID)...
  13. ncbi request reprint Epidemiology of staphylococcal scalded skin syndrome in Germany
    Maja Mockenhaupt
    Dokumentationszentrum schwerer Hautreaktionen dZh, Department of Dermatology, University of Freiburg, Freiburg, Germany
    J Invest Dermatol 124:700-3. 2005
    ..The mortality rate was much lower in children than in adults. Young age was the main risk factor, whereas immunosuppression and consumptive infectious disease were the detected risk factors in adults...